Tumor necrosis factor receptors support murine hematopoietic progenitor function in the early stages of engraftment

Stem Cells

Volumn 28, Issue 7, 2010, Pages 1270-1280

  Pearl Yafe, Michal ^a   Mizrahi, Keren ^a,d   Stein, Jerry ^a   Yolcu, Esma S ^b,c   Kaplan, Ofer ^d   Shirwan, Haval ^b,c   Yaniv, Isaac ^a   Askenasy, Nadir ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c University of Louisville School of Medicine   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Apoptosis; Engraftment; Stem cell transplantation; Tumor necrosis factor

Indexed keywords

FAS ANTIGEN; FAS LIGAND; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMUR; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELLS, CULTURED; HEMATOPOIETIC STEM CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;

MURINAE; MUS;

EID: 77954829475     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.448     Document Type: Article

References (62)

1. Nagafuji K, Takenaka K, Shibuya T et al. Fas antigen (CD95) and hematopoietic progenitor cells. Leuk Lymphoma 1996;24:43-56. (Pubitemid 27060035)
2. Nagata S. Apoptosis by death factor. Cell 1997;88:355-365.
3. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003;3:745-756.
4. Xun CQ, Thompson JS, Jennings CD et al. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood 1994;83:2360-2367.
5. Hill GR, Teshima T, Gerbitz A et al. Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia. J Clin Invest 1999;104:459-467.
6. Aguila HL, Weissman IL. Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells. Blood 1996;87:1225-1231.
7. Baxter GT, Kuo RC, Jupp OJ et al. Tumor necrosis factor-alpha mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J Biol Chem 1999;274:9539-9547.
8. Bryder D, Ramsfjell V, Dybedal I et al. Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation. J Exp Med 2001;194:941-952.
9. Zhang Y, Harada A, Bluethmann H et al. Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF alpha in vitro. Blood 1995;86:2930-2937.
10. Rebel VI, Hartnett S, Hill GR et al. Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level. J Exp Med 1999;190:1493-1504.
11. Backx B, Broeders L, Bot FJ et al. Positive and negative effects of tumor necrosis factor on colony growth from highly purified normal marrow progenitors. Leukemia 1991;5:66-70.
12. Rusten LS, Jacobsen FW, Lesslauer W et al. Bifunctional effects of tumor necrosis factor alpha (TNF alpha) on the growth of mature and primitive human hematopoietic progenitor cells: Involvement of p55 and p75 TNF receptors. Blood 1994;83:3152-3159.
13. Jacobsen SE, Ruscetti FW, Dubois CM et al. Tumor necrosis factor alpha directly and indirectly regulates hematopoietic progenitor cell proliferation: role of colony-stimulating factor receptor modulation. J Exp Med 1992;175:1759-1772.
14. Dybedal I, Guan F, Borge OJ et al. Transforming growth factor-beta1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells. Blood 1997;90:3395-3403.
15. Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003;66:1403-1408. (Pubitemid 38373326)
16. Greil R, Anether G, Johrer K et al. Tuning the rheostat of the myelopoietic system via Fas and TRAIL. Crit Rev Immunol 2003;23:301-322.
17. Dybedal I, Bryder D, Fossum A et al. Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells. Blood 2001;98:1782-1791.
18. Maciejewski J, Selleri C, Anderson S et al. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995;85:3183-3190.
19. Sato T, Selleri C, Anderson S et al. Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells. Br J Haematol 1997;97:356-365.
20. Dybedal I, Yang L, Bryder D et al. Human reconstituting hematopoietic stem cells up-regulate Fas expression upon active cell cycling but remain resistant to Fas-induced suppression. Blood 2003;102:118-126.
21. Vinci G, Chouaib S, Autran B et al. Evidence that residual host cells surviving the conditioning regimen to allogeneic bone marrow transplantation inhibit donor hematopoiesis in vitro-the role of TNF-alpha. Transplantation 1991;52:406-411.
22. Rezzoug F, Huang Y, Tanner MK et al. TNF-alpha is critical to facilitate hemopoietic stem cell engraftment and function. J Immunol 2008;180:49-57.
23. Speiser DE, Bachmann MF, Frick TW et al. TNF receptor p55 controls early acute graft-versus-host disease. J Immunol 1997;158:5185-5190.
24. Moreau G, Leite-De-Moraes M, Ezine S et al. Natural killer cell-dependent apoptosis of peripheral murine hematopoietic progenitor cells in response to Fas cross-linking: involvement of tumor necrosis factor-alpha. Blood 2001;97:3069-3074.
25. Fernandez L, Rodriguez S, Huang H et al. Tumor necrosis factoralpha and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation. Exp Hematol 2008;36:545-558.
26. Pearl-Yafe M, Yolcu ES, Stein J et al. Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis. Exp Hematol 2007;35:1601-1612.
27. Mizrahi K, Pearl-Yafe M, Stein J et al. Regulatory functions of TRAIL in hematopoietic progenitors: murine transplants and human umbilical cord blood. Leukemia 2010 (in press). DOI: 10.1038/leu.2010.97.
28. Pearl-Yafe M, Stein J, Yolcu ES et al. Fas transduces dual apoptotic and trophic signals in hematopoietic progenitors. Stem Cells 2007;25:3194-3203.
29. Pearl-Yafe M, Yolcu ES, Stein J et al. Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactions. Stem Cells 2007;25:1448-1455.
30. Askenasy N, Yolcu ES, Shirwan H et al. Cardiac allograft acceptance after localized bone marrow transplantation by isolated limb perfusion in non-myeloablated recipients. Stem Cells 2003;21:200-207.
31. Jones RJ, Celano P, Sharkis SJ et al. Two phases of engraftment established by serial bone marrow transplantation in mice. Blood 1989;73:397-401. (Pubitemid 19060519)
32. Okada S, Nakauchi H, Nagayoshi K et al. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood 1992;80:3044-3050.
33. Dempsey PW, Doyle SE, He JQ et al. The signalling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 2003;14:193-209.
34. Wilson NS, Dixit V, Ashkenazi A. Death receptor signal transducers: Nodes of coordination in immune signaling networks. Nat Immunol 2009;10:348-355.
35. Liu B, Buckley SM, Lewis ID et al. Homing defect of cultured human hematopoietic cells in the NOD/SCID mouse is mediated by Fas/CD95. Exp Hematol 2003;31:824-832.
36. Askenasy N, Yolcu ES, Yaniv I et al. Fas-ligand as a double-edged immunomodulator to induce transplantation tolerance. Blood 2005;105:1396-1404.
37. Pyatt DW, Stillman WS, Yang Y et al. An essential role for NF-{kappa} B in human CD34+ bone marrow cell survival. Blood 1999;93:3302-3308.
38. Kerzic PJ, Pyatt DW, Zheng JH et al. Inhibition of NF-{kappa}B by hydroquinone sensitizes human bone marrow progenitor cells to TNF-{alpha}-induced apoptosis. Toxicology 2003;187:127-137.
39. Kim H, Whartenby KA, Georgantas RW et al. Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis. Stem Cells 2002;20:174-182.
40. Ratajczak J, Kucia M, Reca R et al. Quiescent CD34+ early erythroid progenitors are resistant to several erythropoietic "inhibitory" cytokines: Role of FLIP. Br J Haematol 2003;123:160-169.
41. Peters SO, Kittler EL, Ramshaw HS et al. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL- 6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996;87:30-37.
42. Cerny J, Dooner M, McAuliffe C et al. Homing of purified murine lymphohematopoietic stem cells: A cytokine-induced defect. J Hematother Stem Cell Res 2002;11:913-922.
43. Von Drygalski A, Alespeiti G, Ren L et al. Murine bone marrow cells cultured ex vivo in the presence of multiple cytokine combinations lose radioprotective and long-term engraftment potential. Stem Cells Dev 2004;13:101-111.
44. Muller S, Rihs S, Dayer Schneider JM et al. Soluble TNF-α but not transmembrane TNF-α sensitizes T cells for enhanced activation-nduced cell death. Eur J Immunol 2009;39:3171-3180.
45. Grell M, Douni E, Wajant H et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995;83:793-802.
46. Drutskaya MS, Ortiz M, Liepinsh DJ et al. Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice. Exp Hematol 2005;33:1348-1356.
47. Zipori D. The renewal and differentiation of hemopoietic stem cells. FASEB J 1992;6:2691-2697.
48. Yaniv I, Stein J, Farkas DL et al. The tale of early hematopoietic cell seeding in the bone marrow niche. Stem Cells Dev 2006;15:4-16.
49. Umland O, Heine H, Miehe M et al. Induction of various immune modulatory molecules in CD34(+) hematopoietic cells. J Leukocyte Biol 2004;75:671-679.
50. Peter ME, Budd RC, Desbarats J et al. The CD95 receptor: Apoptosis revisited. Cell 2007;129:447-450.
51. Chan FK, Chun HJ, Zheng L et al. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 2000;288:2351-2354.
52. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003;114:181-190.
53. Hsu H, Huang J, Shu BH et al. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996;4:387-396. (Pubitemid 26174054)
54. Shu HB, Takeuchi M, Goeddel DV. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci USA 1996;93:13973-13978.
55. Zheng L, Bidere N, Staudt D et al. Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1. Mol Cell Biol 2006;26:3505-3513.
56. Jin Z, El-Deiry WS. Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis. Mol Cell Biol 2006;26:8136-8148.
57. Wang L, Du F, Wang X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 2008;133:693-703.
58. Whartenby KA, Straley EE, Kim H et al. Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation. Blood 2002;100:3147-3154.
59. Gur H, Krauthgamer R, Bachar-Lustig E et al. Immune regulatory activity of CD34+ progenitor cells: Evidence for a deletion-based mechanism mediated by TNF-alpha. Blood 2005;105:2585-2593.
60. Bohana-Kashtan O, Morisot S, Hildreth R et al. Selective reduction of graft-versus-host disease-mediating human T cells by ex vivo treatment with soluble Fas ligand. J Immunol 2009;183:696-705.
61. Secchiero P, Milani D, Gonelli A et al. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells. J Leukocyte Biol 2003;74:223-232.
62. Schmelz K, Wieder T, Tamm I et al. necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB. Oncogene 2004;23:6743-6759.